Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPUS: Doxycycline Pleurodesis for Malignant Pleural Effusions
NCT01411202Phase 2Unknown
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jun 2011
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of doxycycline in malignant pleural effusion (MPE), sponsored by Ottawa Hospital Research Institute. Status: unknown.
02
Drugs
doxycycline
03
Conditions
malignant pleural effusion (MPE)
Beyond the preview
Go deeper on NCT01411202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01411202.